1 Department of Anesthesiology, Critical Care Medicine Program, University of Pittsburgh School of Medicine, 1081 Scaife Hall, Pittsburgh, Pennsylvania 15261; Veterans Administration Hospital, University Drive C, Pittsburgh, Pennsylvania 15240
One hypothesis on the pathogenesis of post-ischemic-anoxic encephalopathy is impaired cerebral perfusion or the no-reflow phenomenon. Therapies aimed at preventing the development of this phenomenon are increased cerebral perfusion pressure (CPP) and hyperventilation or hypercapnia. Using a dog model in which we have described the progressive development of post-ischemic (PI) cerebral hypoperfusion after 15 minutes of global ischemia induced by aortic and vena cavae clamping, our aims in this study were to determine during the PI cerebral hypoperfusion period: (1) cerebrovascular reactivity to CO2, and (2) cerebral blood flow (CBF) autoregulation. Post-ischemic cerebral hypoperfusion to about 50% of normal was not accompanied by raised intracranial pressure (ICP) but cerebrovascular CO2 reactivity was markedly attenuated while maintaining some kind of autoregulatory phenomenon. Cerebral uptake of oxygen was not significantly affected by changing Pacoco2 from 20 to 60 torr at constant CPP or by changing CPP from 64 to 104 torr at constant Pacoco2. These results suggest that increasing both CPP and hypocapnia/hypercapnia would not significantly attenuate PI neurological deficit after global cerebral ischemia. However, in two dogs inadvertently hemodiluted in the PI period, increasing CPP from 50 to 200 torr increased CBF by 200%, suggesting that hemodilution plus increased CPP may be effective therapy for amelioration of post-ischemic-anoxic encephalopathy. The significance of our findings on cerebrovascular CO2 reactivity and autoregulation with respect to the mechanism of the no-reflow phenomenon is discussed.
© 1975 American Heart Association, Inc.
Global Ischemia in Dogs: Cerebrovascular CO2 Reactivity and Autoregulation
Key Words: no reflow • post-ischemic encephalopathy • no-reflow therapy • hemodilution • cerebral perfusion pressure • carbon dioxide • brain oxygen metabolism • post-ischemic hypoperfusion
This article has been cited by other articles:
 |
|
 |
|
  P. M. Macey, L. A. Henderson, K. E. Macey, J. R. Alger, R. C. Frysinger, M. A. Woo, R. K. Harper, F. L. Yan-Go, and R. M. Harper Brain Morphology Associated with Obstructive Sleep Apnea Am. J. Respir. Crit. Care Med., November 15, 2002; 166(10): 1382 - 1387. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Sundgreen, F. S. Larsen, T. M. Herzog, G. M. Knudsen, S. Boesgaard, and J. Aldershvile Autoregulation of Cerebral Blood Flow in Patients Resuscitated From Cardiac Arrest Stroke, January 1, 2001; 32(1): 128 - 132. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Olah, C. Franke, W. Schwindt, M. Hoehn, and M. Fisher CO2 Reactivity Measured by Perfusion MRI During Transient Focal Cerebral Ischemia in Rats Editorial Comment Stroke, September 1, 2000; 31(9): 2236 - 2244. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Demolis, G. Florence, L. Thomas, Y. R. Tran Dinh, J.-F. Giudicelli, J. Seylaz, and N. J. Alkayed Is the Acetazolamide Test Valid for Quantitative Assessment of Maximal Cerebral Autoregulatory Vasodilation? : An Experimental Study • Editorial Comment: An Experimental Study Stroke, February 1, 2000; 31(2): 508 - 515. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Buunk, J. G. van der Hoeven, and A. E. Meinders Cerebrovascular Reactivity in Comatose Patients Resuscitated From a Cardiac Arrest Stroke, August 1, 1997; 28(8): 1569 - 1573. [Abstract] [Full Text]
|
|
|
|
|
|
P. Safar, F. Xiao, A. Radovsky, K. Tanigawa, U. Ebmeyer, N. Bircher, H. Alexander, and S. W. Stezoski Improved Cerebral Resuscitation From Cardiac Arrest in Dogs With Mild Hypothermia Plus Blood Flow Promotion Stroke, January 1, 1996; 27(1): 105 - 113. [Abstract] [Full Text]
|
|